Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNQ3 | O43525 | 7/20 | 0.86 |
| ▸ | KCNQ2 | O43526 | 7/20 | 0.86 |
| ▸ | KCNE1 | P15382 | 6/20 | 0.86 |
| ▸ | KCNQ1 | P51787 | 6/20 | 0.86 |
| ▸ | RAB9A | P51151 | 2/20 | 0.68 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.68 |
| ▸ | BACE1 | P56817 | 1/20 | 0.65 |
| ▸ | TRPV1 | Q8NER1 | 5/20 | 0.60 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.60 |
| ▸ | MEN1 | O00255 | 1/20 | 0.60 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.60 |
| ▸ | LMNA | P02545 | 1/20 | 0.60 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.60 |
| ▸ | NPC1 | O15118 | 1/20 | 0.59 |
| ▸ | RORC | P51449 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14339875 | 0.93 | KCNQ3 (1.00) | KCNQ3KCNQ2KCNE1KCNQ1BACE1 | |
| SCHEMBL2303319 | 0.86 | RAB9A (0.72) | KCNQ3KCNQ2KCNE1KCNQ1RAB9A | |
| SCHEMBL2801974 | 0.84 | KCNQ3 (0.85) | KCNQ3KCNQ2KCNE1KCNQ1RAB9A | |
| SCHEMBL1986996 | 0.83 | KCNQ3 (0.82) | KCNQ3KCNQ2KCNE1KCNQ1RAB9A | |
| SCHEMBL5215207 | 0.83 | KCNQ3 (0.81) | KCNQ3KCNQ2KCNE1KCNQ1RAB9A | |
| SCHEMBL7513604 | 0.83 | TRPV1 (0.83) | KCNQ3KCNQ2KCNE1KCNQ1RAB9A | |
| SCHEMBL3313800 | 0.82 | RAB9A (0.75) | KCNQ3KCNQ2KCNE1KCNQ1RAB9A | |
| SCHEMBL28910371 | 0.82 | TRPV1 (0.71) | KCNQ3KCNQ2KCNE1KCNQ1RAB9A | |
| SCHEMBL8361559 | 0.81 | RAB9A (1.00) | KCNQ3KCNQ2KCNE1KCNQ1RAB9A | |
| SCHEMBL14516640 | 0.81 | KCNQ3 (0.74) | KCNQ3KCNQ2KCNE1KCNQ1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2832733-B1 | 4-ALKANOYLAMINO-3-PYRAZOLONE DERIVATIVE | DAIICHI SANKYO CO LTD (JP) | 2018-08-29 | — | — | EP | disclosed |
| US-9212170-B2 | 4-alkanoylamino-3-pyrazolone derivative | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2015-12-15 | — | — | US | disclosed |
| US-9212170-B2 | 4-alkanoylamino-3-pyrazolone derivative | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2015-12-15 | — | — | US | disclosed |
| US-9212170-B2 | 4-alkanoylamino-3-pyrazolone derivative | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2015-12-15 | — | — | US | disclosed |
| EP-2832733-A1 | 4-ALKANOYLAMINO-3-PYRAZOLONE DERIVATIVE | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2015-02-04 | — | — | EP | disclosed |
| EP-2832733-A1 | 4-ALKANOYLAMINO-3-PYRAZOLONE DERIVATIVE | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2015-02-04 | — | — | EP | disclosed |
| US-20150011552-A1 | 4-ALKANOYLAMINO-3-PYRAZOLONE DERIVATIVE | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2015-01-08 | — | — | US | disclosed |
| US-20150011552-A1 | 4-ALKANOYLAMINO-3-PYRAZOLONE DERIVATIVE | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2015-01-08 | — | — | US | disclosed |
| US-20150011552-A1 | 4-ALKANOYLAMINO-3-PYRAZOLONE DERIVATIVE | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2015-01-08 | — | — | US | disclosed |
| US-20120238750-A1 | AROMATIC COMPOUND | OTSUKA PHARMACEUTICAL CO., LTD. | 2012-09-20 | — | — | US | disclosed |
| US-8236826-B2 | Diarylether derivatives as antitumor agents | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2012-08-07 | — | — | US | disclosed |
| US-8188277-B2 | Aromatic compounds for suppressing the generation of collagen | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2012-05-29 | — | — | US | disclosed |
| US-20100004438-A1 | DIARYLETHER DERIVATIVES AS ANTITUMOR AGENTS | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2010-01-07 | — | — | US | disclosed |
| EP-1957073-A2 | MEDICINAL DRUG | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2008-08-20 | — | — | EP | disclosed |
| US-20070270422-A1 | Aromatic Compounds | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2007-11-22 | — | — | US | disclosed |
| WO-2007066784-A2 | DIARYLETHER DERIVATIVES AS ANTITUMOR AGENTS | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2007-06-14 | — | — | WO | disclosed |
| EP-1773797-A2 | AROMATIC COMPOUNDS | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2007-04-18 | — | — | EP | disclosed |
| WO-2006014012-A2 | AROMATIC COMPOUNDS | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2006-02-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150011552-A1 | 4-ALKANOYLAMINO-3-PYRAZOLONE DERIVATIVE | EPOR, EGLN2, EGLN3 | KCNQ3 889/4885KCNQ2 759/4885KCNE1 997/4885 |
| US-20120238750-A1 | AROMATIC COMPOUND | CBR1, CBR3, CYP1A1 | KCNQ3 1570/4885KCNQ2 1451/4885KCNE1 453/4885 |
| US-20100004438-A1 | DIARYLETHER DERIVATIVES AS ANTITUMOR AGENTS | ROS1, CBR1, CBR3 | KCNQ3 4035/4885KCNQ2 3926/4885KCNE1 2330/4885 |
| US-20070270422-A1 | Aromatic Compounds | COL1A1, COL2A1, COL14A1 | KCNQ3 3700/4885KCNQ2 3623/4885KCNE1 2527/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.